Albireo Pharma Inc (NQ: ALBO )
34.86
USD
-0.22
(-0.63%)
Official Closing Price
Updated: 4:24 PM EST, Feb 26, 2021
Add to My Watchlist
All news about Albireo Pharma Inc
Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
Today 0:31 EST
From Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
February 18, 2021
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2021
Albireo Presents Odevixibat Commercialization Road to $1 Billion
February 11, 2021
Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2020
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
From Benzinga
Albireo Reports Q3 2020 Financial Results and Provides Business Update
November 05, 2020
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
October 23, 2020
Cramer Gives His Opinion On Cloudera, Barrick Gold And More
October 20, 2020
From Benzinga
Albireo Recognizes PFIC Awareness Day 2020
October 05, 2020
First Week of November 20th Options Trading For Albireo Pharma
September 24, 2020
Tags
Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.